Physician profile
Michael S Maher
NPI 1235122755
$1,365.39
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $410 · 2020: $332 · 2021: $438 · 2022: $185.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $707.67 | 2019-2022 | |
| Boston Scientific Corporation | $91.95 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $75.37 | 2019-2021 | |
| Pfizer INC. | $71.91 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $70.96 | 2021-2022 | |
| Medtronic Vascular, INC. | $53.41 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.59 | 2022 | |
| Sanofi-Aventis U.S. LLC | $35.61 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $33.78 | 2019-2021 | |
| Edwards Lifesciences Corporation | $28.06 | 2021 | |
| Amgen INC. | $27.88 | 2019-2022 | |
| Abbott Laboratories | $24.12 | 2019 | |
| Biosense Webster, INC. | $20.15 | 2020 | |
| Chiesi USA, INC. | $18.79 | 2020 | |
| Alnylam Pharmaceuticals INC. | $15.32 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $13.83 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.22 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $11.93 | 2021 | |
| Itamar Medical INC | $10.84 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.